SCHEMBL205808

SCHEMBL205808

CN(C)C1(c2cccs2)CCC(NC(=O)CCCC(=O)N2CCN(Cc3cc4ccccc4o3)CC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.41
LMNA P02545 1/20 0.41
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
HTR2B P41595 6/20 0.38
HTR1A P08908 3/20 0.38
DRD2 P14416 6/20 0.37
DRD4 P21917 2/20 0.37
DRD3 P35462 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
OPRM1 P35372 2/20 0.36
OPRL1 P41146 1/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205262 0.80 ALDH1A1 (0.47) LMNAMEN1KMT2A
SCHEMBL4074077 0.77 OPRM1 (0.51) SMN1; SMN2OPRM1OPRL1
SCHEMBL206892 0.77 ALDH1A1 (0.48) LMNASMN1; SMN2MEN1KMT2AOPRM1
SCHEMBL4075730 0.74 HTR2B (0.60) CA2CA9HTR2BHTR1ADRD2
SCHEMBL4074080 0.74 OPRM1 (0.51) SIGMAR1OPRM1OPRL1
SCHEMBL4079677 0.74 OPRM1 (0.47) OPRM1OPRL1
SCHEMBL206822 0.72 OPRM1 (0.47) LMNAHTR2BSMN1; SMN2MEN1KMT2A
SCHEMBL206098 0.71 MAPK1 (0.41) MAPK1SMN1; SMN2MEN1KMT2AOPRM1
SCHEMBL4079669 0.71 OPRM1 (0.45) OPRM1OPRL1
SCHEMBL4079674 0.71 OPRM1 (0.45) OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed